Multidisciplinary Symposium - Prostate Cancer

Cancer Imaging

Volumn 1, Issue 1, 2010, Pages 44-51

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOCHEMICAL RECURRENCE; CANCER LOCALIZATION; CANCER STAGING; CONFERENCE PAPER; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; PROSTATE CANCER; PROSTATECTOMY; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 84941563727     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330/00/010044+08     Document Type: Conference Paper

References (51)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1998; 48: 6-29.
2. Imperial Cancer Research Fund. Cancer Statistics (online: http://www.icnetuk/research/factsheet/canstats.html). 1995.
3. American Cancer Society. Cancer Facts and Figures. 1998. http://www.cancer.org.statisticscff98/graphicaldatahtml.
4. Catalona WJ. Surgical management of prostate cancer: contemporary results with anatomic radical prostatectomy. Cancer 1995; 75: 1903-8.
5. Donovan JL, Frankel SJ, Faulkner A, Selley S, Gillatt S, Hamdy FC. Dilemmas in treating early prostate cancer: the evidence and a questionaire survey of consultant urologists in the United Kingdom. Br Med J 1999; 318: 299-300.
6. Jewett HJ. Significance of the palpable prostatic nodule. J Am Med Assoc 1956; 160: 838-939.
7. Smith DS, Catalona WJ. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 1995; 45: 70-4.
8. Voges GE, McNeal JE, Redwine E, Freiha FS, Stamey TA. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate. Cancer 1992; 69: 520-6.
9. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993; 71: 3582-93.
10. Partin AW, Yoo J, Ballentine Carter JY, Pearson JD, Chan DW, Epstein JI, Walsh PC. The use of prostate specific antigen, clinical stage and gleason score to predict pathological stage in men with localized prostate cancer. J Urol 1993; 150: 110-5.
11. Kleer E, Oesterling JE. PSA and staging of localized prostate cancer. Urol Clin North Am 1993; 20: 695-704.
12. Jager GJ, Barentsz JO. In: Husband J, ed. Oncology Imaging. Prostate Cancer 1998; 239-57.
13. Langlotz CP. Benefits and costs of MR imaging of prostate cancer. MR Clin N Am 1996; 4: 533-45.
14. Schiebler ML, Schnall MD, Pollack HM, Lenkinski RE, Tomaszewski JE, Wein AJ, Whittington R, Rauschning W, Kressel HY. Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 1993; 189: 339-52.
15. Chernoff DM, Hricak H, Higgins CB, Hricak H. In: Hricak H, ed. Magnetic Resonance Imaging of the Body. The Male Pelvis: Prostate and Seminal vesicles, 3rd edition. New York: Lippincott-Raven Press, 1997: 875-900.
16. Ramchandani P, Schnall MD, LiVolsi VA, Tomaszewski JE, Pollack HM. Senile amyloidosis of the seminal vesicles mimicking metastatic spread of prostatic carcinoma on MR images. Am J Radiol 1993; 161: 99-100.
17. Jager G, Ruijter E, de la Rosette J, van de Kaa CA. Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images. Eur J Radiol 1997; 7: 552-4.
18. Langlotz CP, Schnall MD, Pollack H. Staging of prostatic cancer: Accuracy of MR imaging. Radiology 1995; 194: 645-6.
19. Jager GJ, Thornbury J, Barentsz JO et al. MR staging in prostate cancer (pc): influence on patient outcome and effective analysis. Abstract. RSNA 1998; 181.
20. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, Hamper UM, Walsh PC, McNeil BJ. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med 1990; 323: 621-6.
21. Rørvik J, Halvorsen OJ, Albrektsen G, Ersland L, Daehlin L, Haukaas S. MR imaging with an endorectal coil for staging of clinically localised prostate cancer prior to radical prostatectomy. Eur Radiol 1999; 9: 29-34.
22. Schnall MD, Imai Y, Tomaszewski JE, Pollack HM, Lenkinski RE, Kressel HY. Prostate cancer: local staging with endorectal surface coil MR imaging. Radiology 1991; 178: 797-802.
23. Hricak H, White S, Vigneron DB, Kurhanewicz J, Kosco A, Levin D, Weiss J, Narayan P. Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal-pelvic phased-array coils. Radiology 1994; 193: 703-9.
24. Bartolozzi C, Menchi I, Lencioni R, Serni S, Lapini A, Barbanti G, Bozza A, Amorosi A, Manganelli A, Carini M. Local staging of prostate carcinoma with endorectal coil MR imaging: correlation with whole mount radical prostatectomy specimens. Eur Radiol 1996; 6: 339-45.
25. Langlotz CP, Schnall MD, Malkowicz SB, Schwartz JS. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Acad Radiol 1996; 3: 24-7.
26. Chelsky MJ, Schnall MD, Seidmon EJ, Pollack HM. Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer. J Urol 1993; 150: 391-5.
27. Outwater E, Petersen RO, Siegelman ES, Gomella LG, Chernesky CE, Mitchell DG. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 1994; 193: 333-9.
28. White S, Hricak H, Forstner R, Kurhanewicz J, Vigneron DB, Zaloudek CJ, Weiss JM, Narayan P, Carroll PR. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology 1995; 195: 385-90.
29. Kedar RP, Kier R, Viner N. Proceedings of the International Society of Magnetic Resonance in Medicine (poster ISMRM, Philadelphia) nr.1106, 1999.
30. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological Evaluation of lymph node metastases in patients with cervical cancer. J Am Med Assoc 1997; 278: 1096-101.
31. Jager GJ, Barentsz JO, Oosterhof G, Ruijs JHJ. 3D dimensional MR imaging in nodal staging of bladder and prostate cancer. Am J Radiol 1996; 1503-7.
32. Barentsz JO. MR-intervention in the pelvis: an overview and first experiences in MR-guided biopsy in nodal metastases in urinary bladder cancer. Abdominal Radiol 1997; 22: 524-30.
33. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation by CT scanning after bipedal lymphangiography. Radiology 1995; 194: 349-55.
34. Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994; 190: 315-22.
35. Wolf JS, Cher M, dalla'Era M, Presti JC, Hricak H, Carroll PR. The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 1995; 153: 993-9.
36. Haukaas S, Rørvik J, Halvorsen OJ, Foellings M. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer. Br J Urol 1997; 79: 770-6.
37. Algra PR, Bloem JL, Tissing H, Falke THM, Arndt JW, Verboom LJ. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. RadioGraphics 1991; 11: 219-323.
38. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumour vascularity. Eur J Radiol 1998; 4: 517-27.
39. Jager G, Ruijter E, Kaa van de C, de la Rosette J, Oosterhof G, Thornbury J, Ruijs J, Barentsz J. Dynamic Turbo-flash subtraction technique for contrast-enhanced MR images of the prostate: correlation with histopathology. Radiology 1997; 203: 645-52.
40. Brown G, Macvicar DA, Ayton V, Husband JE. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 1995; 50: 601-6.
41. Preziosi P, Di Giambattista G, Di Renzi P. Endorectal-coil Magnetic Resonance Imaging with dynamic subtraction technique in prostate cancer: evalaution of tumoral tissue behaviour with the time/signal intensity curve analysis (abstract). Radiology 1998; 209P: 259.
42. Kurhanewicz J, Males R, Sokolov D. Combined endorectal/phased-array MR imaging and 3-D H-MR Spectroscopic imaging for improved diagnosis of extracapsular extension in prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia), 1998.
43. Heerschap A, Jager GJ, van der Graaf M, Barentsz JO, de la Rosette J, Oosterhof G, Ruijter ETG, Ruijs SHJ. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. Anticancer Res 1997; 17: 1455-60.
44. Kurhanewicz J, Vigneron DB, Hricak H, Narayan P, Carrol P, Nelson SJ. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.77-cm3) spatial resolution. Radiology 1998; 198: 795-805.
45. Vigneron DB, Males R, Noworolski S. 3D MRSI of prostate cancer: correlations with histologic grade. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia), 1998.
46. Males R, Vigneron DB, Nelson AD. Addition of MR spectroscopic imaging to mri significantly improves detection and localization of prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine (abstract ISMRM, Philadelphia), 1998.
47. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymphnodes with MR imaging. Radiology 1990; 175: 494-8.
48. Taupitz M, Barentsz JO, Tuerk I, Beyersdorff D, Fleige B, Hamm BK. MR lymphography using USIOP. Results of a clinical phase 3 trial in 31 patients with urological tumors (abstract). Radiology 1998; 209P: 336.
49. Presti JC, Hricak H, Narayan P, Shinohara K, White S, Carroll PR. Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. Am J Radiol 1996; 166: 103-8.
50. Yu KK, Hricak H, Alagappan R, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 1997; 202: 697-702.
51. Jager GJ, Severens JL, Thornbury JR, de la Rosette JJMCH, Ruijs SHJ, Barentsz JO. Prostate cancer staging: should MR imaging be used: a decision analytic approach. Radiology 2000; 215: 445-51.